Corneal endothelial autocrine VIP enhances its integrity in stored human donor corneoscleral explant.
Corneal endothelial autocrine VIP enhances its integrity in stored human donor corneoscleral explant.
复制标题
角膜内皮自分泌 VIP 增强了储存的人类供体角巩膜外植体的完整性。
DOI:
10.1167/iovs.10-5983
复制
发表时间:
2011
影响因子:
4.4
通讯作者:
Molloy,Joseph
中科院分区:
文献类型:
--
作者:
Koh,Shay-WheyM;Gloria,Dante;Molloy,Joseph
Purpose.: To demonstrate corneal endothelial (CE) integrity enhanced during eye banking by a brief treatment of human donor corneoscleral explant (explant) with CE autocrine trophic factor vasoactive intestinal peptide (VIP).Methods.: Paired explants were used as control versus VIP (10 nM)-treated before storage in corneal storage medium (4 C). CE ciliary neurotrophic factor receptor (CNTFRα) and CNTF (0.83 nM) responsiveness in connexin 43 upregulation were monitored (Western blot analysis). CE damage in CNTF-modulated explants and corneal buttons from explants was quantified by analysis of panoramic and microscopic images of the alizarin red-stained corneal endothelium. CE cells scraped from the Descemet's membrane were counted. CE VIP receptor was demonstrated (Western blot analysis).Results.: CE cells in every VIP-treated, freshly dissected explant demonstrated higher CNTFRα levels than controls (100% vs. 142%±15%; P= 0.014; 7 pairs stored for 4 to 25 days). Nine days after VIP treatment of previously preserved explants, CNTF responsiveness was 174%±23%(P= 0.023; 4 pairs) of controls. Panoramic images of explants and corneal buttons revealed that VIP treatment reduced CE damage to 75%±6%(P= 0.023; 4 pairs) and 71%±11%(P= 0.016; 9 pairs) of controls, respectively, whereas CE damage to 39%(2 pairs) and 23%±4%(P< 0.001; 7 pairs), respectively, was revealed in microscopic images. Twenty-one days after VIP treatment of previously preserved explants, CE cell retention was 206%±38%(P= 0.008; 14 pairs) of the control. CE cells from human donor corneas expressed VIP receptor VPAC1 (not VPAC2).Conclusions.: CE integrity during eye banking was enhanced by a brief treatment of the explant with the CE autocrine VIP.